CClinicalTrials.gg
Sign In
WithdrawnNCT04412135SPIRIHEMATOUpdated Jun 29, 2026

The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality

An observational study in Hematologic Cancer, sponsored by University Hospital, Limoges. Withdrawn. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-29.

Sponsored by University Hospital, Limoges · Observational

Why this study was withdrawn
Sponsor decision
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
0
Ages
18 Years and older
Sex
All
01

Study summary

The management of patients with malignant hemopathy is based on comprehensive management. In this context and faced with the various difficulties encountered by cancer patients, the question of spirituality and its experience is central. Spirituality refers to the person's attachment to what inspires and gives him foundation, as well as the beliefs, values, and existential experiences associated with it, whether these are religious in nature or not. Although the concept has been identified as a resource in the literature and widely treated in an end-of-life context, assessing the needs of patients with hematological cancer and their loved ones in terms of spirituality from the initiation of treatment does not has not been developed

02

Conditions studied

  • Hematologic Cancer
03

In context

Hematologic Neoplasms

1,464 studies on the registry are indexed under Hematologic Neoplasms; 433 are open to participants now.

Browse Hematologic Neoplasms studies →

Lead sponsor

University Hospital, Limoges is the lead sponsor of 255 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

hematologic cancer patient and family member

Inclusion criteria

  • Aged ≥ 18 years with a recent diagnosis of hematological cancer (lymphoma or leukemia) and in treatment;
  • Patients who speak and read French;
  • Patients in general condition (physical and mental) judged emotionally and physically fit by the referring nurse to answer the questionnaires;
  • Patients benefiting from a social security scheme,
  • Patients who signed the non-objection form after being informed of the study,

family person:

  • Have been designated by the patient as being the loved one they wish to include with them;
  • Aged ≥ 18 years;
  • Fluent in and reading French;
  • Having signed the non-objection form after being informed of the study.

Exclusion criteria

Exclusion Criteria:

  • Patients in recurrence / progress or in remission of cancer;
  • Patients in the terminal phase of the disease.

Family person:

person in the curative phase of cancer

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
0 participants (actual)
Patient registry
No

Interventions

  • Otherspirituality

    Patients will take three questionnaires (FACIT-Sp, Euroqol 5 dimensions and ESAS)

06

What researchers measure

Primary outcomes

  1. FACIT-Sp questionnaire

    Time frame: 15 minutes

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04412135
Lead sponsor
University Hospital, Limoges
Responsible party
Sponsor
First posted
Jun 2, 2020
Start date
Jun 2020 (estimated)
Primary completion
Feb 2021 (estimated)
Completion
Jun 2021 (estimated)
Last update
Jun 29, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Hematologic Neoplasms→

Other studies from this sponsor

University Hospital, Limoges

Start the discussion